Skip to content

​Tachmed and Paragraf enter partnership to scale graphene-powered diagnostics 

Tachmed and Paragraf have entered into a strategic partnership to bring scalable, cost-effective, and accurate diagnostic testing to homes and primary care clinics globally.

The partnership will focus on the integration of Paragraf’s proprietary graphene field-effect transistor (GFET) molecular sensor into Tachmed’s innovative digital health platform, TachShield. This cloud-based system combines rapid diagnostic tests, connected devices, software, and APIs through a single mobile app, offering a seamless experience for patients, health service providers, and clinicians.

 ​

Tachmed and Paragraf have entered into a strategic partnership to bring scalable, cost-effective, and accurate diagnostic testing to homes and primary care clinics globally.The partnership will focus on the integration of Paragraf’s proprietary graphene field-effect transistor (GFET) molecular sensor into Tachmed’s innovative digital health platform, TachShield. This cloud-based system combines rapid diagnostic tests, connected devices, software, and APIs through a single mobile app, offering a seamless experience for patients, health service providers, and clinicians. 

Read More Graphene-Info – Graphene industry portal